Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies
暂无分享,去创建一个
Arno Villringer | Harald E. Möller | Karsten Müller | Matthias L. Schroeter | Georg A. Becker | Osama Sabri | Annette Horstmann | Stefan Frisch | Henryk Barthel | Juergen Dukart | Barbara Vogt | J. Dukart | A. Villringer | S. Frisch | K. Müller | Annette Horstmann | M. Schroeter | H. Möller | O. Sabri | H. Barthel | B. Vogt | G. Becker
[1] 美晴 佐村木,et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease , 2007 .
[2] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[3] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[4] Joel S. Karp,et al. Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI–PET scanning , 2005, NeuroImage.
[5] L A Hansen,et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD , 2002, Neurology.
[6] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[7] Alberto Pupi,et al. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[8] Matthias L. Schroeter,et al. Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients , 2009, NeuroImage.
[9] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[10] Alexander Hammers,et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18 , 2008, Psychiatry Research: Neuroimaging.
[11] Alexander Hammers,et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging , 2009, NeuroImage.
[12] Albert Gjedde,et al. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease , 2009, NeuroImage.
[13] C. DeCarli,et al. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? , 2007, Neurology.
[14] D. Yves von Cramon,et al. Neural networks in frontotemporal dementia—A meta-analysis , 2008, Neurobiology of Aging.
[15] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[16] K. Ishii,et al. Comparison of gray matter and metabolic reduction in mild Alzheimer’s disease using FDG-PET and voxel-based morphometric MR studies , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[17] K. Zilles,et al. Areas 3a, 3b, and 1 of Human Primary Somatosensory Cortex 2. Spatial Normalization to Standard Anatomical Space , 2000, NeuroImage.
[18] C. Svarer,et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] Tetsuya Mori,et al. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease , 2002, Journal of the Neurological Sciences.
[20] Jerry L Prince,et al. Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[22] N. Foster,et al. Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis , 1995, Journal of computer assisted tomography.
[23] Gereon R. Fink,et al. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern , 1994, European Journal of Nuclear Medicine.
[24] K. Ishii,et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] L. Mosconi,et al. Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[26] Ralph Buchert,et al. Adjusted Scaling of FDG Positron Emission Tomography Images for Statistical Evaluation in Patients With Suspected Alzheimer's Disease , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[27] Henry Brodaty,et al. The differentiation of mild frontotemporal dementia from Alzheimer's disease and healthy aging by neuropsychological tests , 2004, International Psychogeriatrics.
[28] Christian Degueldre,et al. Voxel‐based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease , 2000, Human brain mapping.
[29] D. Yves von Cramon,et al. Towards a nosology for frontotemporal lobar degenerations—A meta-analysis involving 267 subjects , 2007, NeuroImage.
[30] L. White,et al. Structure of the human sensorimotor system. I: Morphology and cytoarchitecture of the central sulcus. , 1997, Cerebral cortex.
[31] A. Evans,et al. Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] I. Lemahieu,et al. Differential Regional Cerebral Uptake of 18F-Fluoro-2-Deoxy-D-Glucose in Alzheimer’s Disease and Frontotemporal Dementia at Initial Diagnosis , 2001, European Neurology.
[33] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[34] F Fazekas,et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] Klemens Scheidhauer,et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] J. S. Lee,et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.